Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +0.39% | -2.28% | -12.88% |
Evolution of the average Target Price on BioXcel Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BioXcel Therapeutics, Inc.
Canaccord Genuity | |
UBS | |
Truist Securities | |
HC Wainwright | |
Goldman Sachs | |
Mizuho Securities | |
Guggenheim | |
Jefferies & Co. | |
Berenberg Bank | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- BTAI Stock
- Consensus BioXcel Therapeutics, Inc.